In a groundbreaking study published in the British Medical Journal, researchers shed light on a significant correlation between Gynecomastia, the enlargement of breast tissue in men not due to obesity, and an elevated risk of premature mortality. The study, the first of its kind, emphasizes the importance of understanding the underlying factors associated with Gynecomastia and the subsequent health risks that may lead to an increased likelihood of death before age 75.
Understanding Gynecomastia
Gynecomastia, often attributed to hormonal imbalances, affects a substantial proportion of men, ranging from one-third to two-thirds, depending on age. It differs from pseudo-Gynecomastia, colloquially known as ‘man boobs,’ which is typically linked to excess weight. The condition can manifest at any age but peaks during the neonatal period, puberty, and older ages. During older ages, declining testosterone levels and weight gain often exacerbate the condition.
Previous research hinted at a connection between Gynecomastia and heightened health risks, but the study aimed to explore if there is a direct association with premature mortality.
The Study
The researchers used Danish National Health and Population Registry data to examine 23,429 men diagnosed with Gynecomastia between 1995 and 2021. A control group of 117,145 men without the condition was also included for comparison. The men with Gynecomastia were further categorized based on whether the condition was idiopathic or associated with a known pre-existing risk factor or medication.
Key Findings
- Increased Mortality Risk: The study revealed a 37% higher risk of premature death among men with Gynecomastia compared to those without the condition.
- Risk Stratification: The data showed that the risk of death was highest among those with a known pre-existing condition, with 75% higher odds compared to those with Idiopathic Gynecomastia.
- Association with Specific Conditions: Pre-existing cancers circulatory, lung, and gut disorders were strongly associated with heightened mortality risks. Neurological diseases, however, were linked to a 29% lower risk.
- Cancer-Specific Risks: Cancers of the digestive tract, genitalia, and lymph system were particularly associated with increased mortality risks.
- Gut Disease Risks: Liver diseases and disorders of the gallbladder, biliary tract, and pancreas were linked to the greatest risks among gut diseases.
Clinical Implications
The study underscores the need for thorough clinical examinations in males diagnosed with Gynecomastia to identify underlying risk factors. Notably, individuals with a known pre-existing risk factor were found to be at the highest risk of premature mortality.
Limitations and Future Considerations
The study acknowledges its observational nature, which cannot establish causal factors. Factors such as obesity, exposure to endocrine-disrupting chemicals, and steroid use were not fully accounted for. The researchers propose that Gynecomastia may be intertwined with later health risks, potentially exacerbated by the drugs used for treatment.
Conclusion
This groundbreaking study provides valuable insights into the link between Gynecomastia and premature mortality. Clinicians are urged to conduct thorough examinations and consider underlying risk factors, especially in individuals with a known pre-existing risk factor. While further research is needed to unravel the intricacies of this association, these findings emphasize the importance of addressing Gynecomastia holistically within clinical practice.
Reference
- Men with enlarged breast tissue may be at heightened risk of death: Study [Internet]. Accessed on January 29, 2024. Available from: https://health.economictimes.indiatimes.com/news/industry/men-with-enlarged-breast-tissue-may-be-at-heightened-risk-of-death-study/106921562
About Docquity
If you need more confidence and insights to boost careers in healthcare, expanding the network to other healthcare professionals to practice peer-to-peer learning might be the answer. One way to do it is by joining a social platform for healthcare professionals, such as Docquity.
Docquity is an AI-based state-of-the-art private & secure continual learning network of verified doctors, bringing you real-time knowledge from thousands of doctors worldwide. Today, Docquity has over 400,000 doctors spread across six countries in Asia. Meet experts and trusted peers across Asia where you can safely discuss clinical cases, get up-to-date insights from webinars and research journals, and earn CME/CPD credits through certified courses from Docquity Academy. All with the ease of a mobile app available on Android & iOS platforms!
